Catalent to acquire gene therapy service firm Paragon

Monday, April 15, 2019 - 15:30 in Mathematics & Economics

The $1.2 billion deal is the latest designed to support the flood of gene therapies in development

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net